非透析慢性肾脏病中铁调素、铁指标与骨矿物质代谢的关联
本研究基于2238例非透析慢性肾脏病(CKD)患者的多中心前瞻性队列数据,分析铁调素、铁指标与骨矿物质代谢标志物之间的关联。多变量线性回归显示,转铁蛋白饱和度(TSAT)升高与血磷降低及25-羟基维生素D(25OHD)升高相关,铁蛋白升高与完整甲状旁腺激素(iPTH)降低相关,而血磷、25OHD和iPTH均与铁调素独立相关。
要点
- TSAT每增加10%,血磷降低0.013 mmol/L,对数25OHD升高0.022 nmol/L。
- 对数铁蛋白每增加1 pmol/L,对数iPTH降低0.080 ng/L。
- 血磷、25OHD和iPTH均与铁调素独立相关,炎症亚组中关联最强。
核心结论
- 骨矿物质代谢标志物与铁状态指标(包括铁调素)在非透析CKD患者中密切关联。
主要发现
- TSAT每增加10%,血磷降低0.013 mmol/L(95%CI -0.021至-0.004;P=0.003),对数25OHD升高0.022 nmol/L(95%CI 0.005-0.040;P=0.019)。
- 对数铁蛋白每增加1 pmol/L,对数iPTH降低0.080 ng/L(95%CI -0.122至-0.039;P<0.001)。
- 血磷每增加1单位,铁调素平方根增加0.594(95%CI 0.257-0.932;P=0.001);对数25OHD每增加1单位,铁调素平方根降低0.270(95%CI -0.431至-0.108;P=0.001);对数iPTH每增加1单位,铁调素平方根增加0.115(95%CI 0.004-0.226;P=0.042)。
- 亚组分析显示,血磷、25OHD与铁调素的关联在正炎症组中最强。
临床怎么用
- 在非透析CKD患者中评估铁状态时,应关注其与骨矿物质代谢标志物的相互关联,反之亦然。
局限性
- 原文未明确报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Few studies have examined the association between hepcidin, iron indices and bone mineral metabolism in non-dialysis chronic kidney disease (CKD) patients. METHODS: We reviewed the data of 2238 patients from a large-scale multicenter prospective Korean study (2011-16) and excluded 214 patients with missing data on markers and related medications of iron and bone mineral metabolism, hemoglobin, blood pressure and causes of CKD. Multivariate linear regression analysis was used to identify the association between iron and bone mineral metabolism. RESULTS: The proportion of CKD Stages 1-5 were 16.2, 18.7, 37.1, 21.6 and 6.4%, respectively. Per each 10% increase in transferrin saturation (TSAT), there was a 0.013 mmol/L decrease in phosphorus [95% confidence interval (CI) -0.021 to -0.004; P = 0.003] and a 0.022 nmol/L increase in logarithmic 25-hydroxyvitamin D (Ln-25OHD) levels (95% CI 0.005-0.040; P = 0.019). A 1 pmol/L increase in Ln-ferritin was associated with a 0.080 ng/L decrease in Ln-intact parathyroid hormone (Ln-iPTH; 95% CI -0.122 to -0.039; P < 0.001). Meanwhile, beta (95% CI) per 1 unit increase in phosphorus, Ln-25OHD and Ln-iPTH for the square root of the serum hepcidin were 0.594 (0.257-0.932; P = 0.001), -0.270 (-0.431 to -0.108; P = 0.001) and 0.115 (0.004-0.226; P = 0.042), respectively. In subgroup analysis, the relationship between phosphorus, 25OHD and hepcidin was strongest in the positive-inflammation group. CONCLUSIONS: Markers of bone mineral metabolism and iron status, including hepcidin, were closely correlated to each other. Potential mechanisms of the relationship warrant further studies.
引用
- Min HK, Sung SA, Oh YK, et al. Hepcidin, iron indices and bone mineral metabolism in non-dialysis chronic kidney disease. Nephrol Dial Transplant. 2020. PMID: 30053139. doi:10.1093/ndt/gfy235
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。